ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 258625 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 258625; 2) Community: the network communities that were significantly associated with the response to NSC 258625; 3) Molecule: the relationships between components within communities and NSC 258625; 4) MDR: the compounds that were significantly associated with the NSC 258625.

NSC Compound Enrichment Correlation
NSC 708046 Null 0.00165587325865811 0.64707774
NSC 727286 6-(bromomethyl)-1,4-anthracenedione. 0.00165587325865811 0.51072037
NSC 30916 MP 317 0.00174331675630443 0.59739652
NSC 626874 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-, hydrochloride 0.00174331675630443 0.57193873
NSC 645991 Null 0.00174331675630443 0.63048311
NSC 658828 Null 0.00174331675630443 0.6238576
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.00174331675630443 0.47581507
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.00174331675630443 0.40535309
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.00174331675630443 0.66166707
NSC 758881 Orlistat (USAN) 0.00174331675630443 0.12802707
Total:91  Current:8    [First] [Prev] [Next] [Last]